Metraipolis › archive › dc_1ecb4079d90d
Real-world use of disease-modifying therapy in persons with multiple sclerosis aged 55 and over — Europe PMC PMID:41000459
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41000459
- DOI
- 10.1136/bmjno-2025-001108
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T19:51:57.659Z
- SHA-256 of the archived text
84528b836e010eeebffa7ac9db43677d862197d1e611254423ca7fe7e75ddb8f- Stable URL of this page
https://metraipolis.com/documento/dc_1ecb4079d90d
How to cite
Real-world use of disease-modifying therapy in persons with multiple sclerosis aged 55 and over — Europe PMC PMID:41000459 — Europe PMC (en), https://europepmc.org/article/MED/41000459 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1ecb4079d90d (Metraipolis archive dc_1ecb4079d90d, sha256 84528b836e010eeebffa7ac9db43677d862197d1e611254423ca7fe7e75ddb8f)
BibTeX
@misc{dc1ecb4079d90d,
title = {Real-world use of disease-modifying therapy in persons with multiple sclerosis aged 55 and over — Europe PMC PMID:41000459},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41000459},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1ecb4079d90d; sha256 84528b836e010eeebffa7ac9db43677d862197d1e611254423ca7fe7e75ddb8f},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41000459. Agents can read the archived copy with the MCP tool read_document.